Post on 11-Jun-2020
4
SCOPE OF THE MEETING
The Egyptian Society or Hypertension has developed this year’s program with the assistance of members of local and international program com-mittees, who are well known for their extensive expertise in a wide range of blood pressure-related topics, ranging from epidemiology and clinical research through to mechanistic studies. Keynote and plenary presenta-tions on novel approaches for identifying and treating hypertension and related cardiovascular disease, recent advances in our understanding the pathogenesis of hypertension, as well as reviewing the population studies.
Stroke and diabetes will be just two of the recurring themes that will be discussed in presentations throughout the meeting.
The meeting will feature something for everyone, from the practicing clinician, to the clinical researcher through to basic scientists studying the biology of different aspects of blood pressure and cardiovascular diseases. It will provide opportunities for young investigators to present their latest work during the poster sessions, and they will also be eligible for a number of awards based on scientific merit.
On behalf of the organizing committee, we welcome you to participate in this Annual Meeting and be part and cause of its success.
Chairperson of the MeetingProf. Wafaa El-Aroussy
Prof. and Head of Cardiovascular Medicine Depart. Cairo University
President of the SocietyProf. M. Mohsen Ibrahim
Prof. of Cardiovascular Medicine Cairo University
5
SCIENTIFIC COMMITTEE (ALPHABETICAL ORDER)
Abdel Fatah FrereAbdel Moaty El-KieyAbdelmoniem IbrahimAdel El-EtribyAhmed Abdel Latif Ramadan Ahmed El-HawaryAhmed Kamal MotawieAhmed MagdyAhmed RozzaAmir Abdel WahabAmr Al-MeligiAshraf RedaAtef El-BahryAyman Abol MagdAziz MadkourAzza ErakiAzza FarragDalia El-RamicyEhab El-HefnyEssam BalighEzz El-Din El-SawyFathy MakladyFayez FayekGalal El- SaidGamela M. Nasr Ghada El-Sayed Ghada Reda AwadinHanaa FeriegHany RagyHesham Abol EnienHesham BoshraHesham HegazyHesham Salah El-DinHossam KandilHussien RizkIman El-Safty
Zagazieg UniversityMilitary Medical AcademyCairo UniversityAin Shams UnievrsityAl Azhar UniversitySuez Canal UniversityAl-Azhar UniversityNational Heart InstituteAl-Azhar UniversityCairo UniversityCairo UniversityMenofia UniversityPort Said UniversityAl-Azhar UniversityAl-Azhar UniversitySuez Canal UniversityCairo UniversityCairo UniversityAl-Azhar UniversityCairo UniversityAl-Azhar UniversitySuez Canal UniversityCairo UniversityCairo UniversitySuez canal UniversityCairo UniversityCairo UniversityAl-Azhar UniversityNational Heart InstituteTanta UniversityBeni Suif UniversitySuez Canal UniversityCairo UniversityCairo UniversityCairo UniversityMansoura University
6
Karim SaidKhaled BarakaKhaled El-RabbatKhaled ShoukryKhaled SorourM. Mohsen IbrahimMagdy Abdel HamidMaher Fouad RamzyMahmoud Hassanein Medhat Ashmawy Mohamed Abdel GhanyMohamed Abdel MaguidMohamed Awad TaherMohamed OrabyMohamed SobhyMohamed Wafaie Abol EnienMokhtar GomaaMuhamed H. MesalmNashwa El- HagrasyOmar AwwadOmar El-KhashabOsama SanadRamez GuindyRamzy El-MawardySameh EmilSherif El-TobgySherif HafezSherif HamdySoliman GhariebWael El-NaggarWafaa El-AroussyWagdy AyadYasser BaghdadyYasser SharafZeinab Ashour
Cairo UniversityMenia UniversityBanha UniversityMilitary Medical AcademyCairo UniversityCairo UniversityCairo UniversityCairo UniversityAlexandria UniversityTanta UniversityCairo UniversityCairo UniversityAin Shams UnievrsitySuez Canal UniversityAlexandria UniversityZagazieg UniversityAl-Azhar UniversityCairo University6th October UnievrsityAin Shams UnievrsityCairo UniversityBanha UnievrsityAin Shams UnievrsityAin Shams UnievrsityMilitary Medical AcademyCairo UniversityCairo UniversityCairo UniversityCairo UniversityCairo UniversityCairo UniversityAlexandria UniversityCairo UniversityCairo UniversityCairo University
SCIENTIFIC COMMITTEE (ALPHABETICAL ORDER)
7
Dr. Garry JenningsASPH Presidential LecturerBaker IDI Heart & Diabetes Institute, OC Chair & Program ChairPresident of the Association of Australian Medical Research Institutes, the High Blood Pressure Research Council of Australia and Head, WHO Collaborating Centre for Research and Training in Cardiovascular Health.
Dr. Christian DellesConsultant Physician Institute for Cardiovascular and Medical Sciences,University of Glasgow, UKHis research is in the areas of oxidative stress and endothelial function as pathogenetic factors of hypertension and other cardiovascular disorders. Currently he focuses on studies into biomarkers of cardiovascular and renal disease with a particular interest in proteomic approaches.
INTERNATIONAL FACULTY
8
EGY Congress for International Conferences & Affairs
Email: egy.congress@yahoo.com - ehs@link.net
Cellular: +20111-9422298 Telephone: (+202) 2794-8877
Fax: (+202) 2794-8879 Website: www.ehs-egypt.net
Mrs. Fatheya Al-Said Mrs. Rehab M. El-Ashkar
Language: All conference sessions are in English;
no instant translation.
Registration:
- Will be open according to the following schedule:
o Wednesday 17th April 8:00 – 15:00
o Thursday 18th April 8:00 – 15:00
Website of Conference: www.ehs-egypt.net
ORGANIZING OFFICE IN CHARGE
SECRETARIAT OF THE MEETING
IMPORTANT INFORMATION
9
Companies Acknowledgement
Novartis
Pfizer
Astra Zeneca
Sanofi
Boehringer Ingelheim
Servier
Rameda
Delta Pharma
Global Napi
October Pharma
Merck
Habib Scientific office
Al Ahram Scientific Office
Eipico
12
We
dn
es
da
y
17
th A
pr
il 2
01
3Session (I) 9:00 - 10:00
Session (II) 10:00 – 11:00
Resistant Hypertension
Salt Survey in Egypt- The Pilot Study
Chairpersons: Amir Abdel Wahab, MD - Mokhtar Gomaa, MD Wafaa El-Aroussy, MD
Chairpersons: Ahmed Kamal Motawie, MD; Christian Delles, MD; Hesham Salah El-Din, MD; M. Mohsen Ibrahim, MD
9:00 - 10:00 Case Presentation: An elderly woman with difficult to treat hypertension
M. Mohsen Ibrahim
10:00-10:10 Background Wafaa El-Aroussy
10:10-10:20 Methodology Ghada Reda Awadin
10:20-10:35 Results: Profile Ghada Sayed
10:35-10:50 Laboratory Data Dalia El-Ramicy
10:50-11:00 Closing remarks Hussien RizkM. Mohsen Ibrahim
13
Plenary Lectures I & II 11:00 – 12:00
Session (III) 12:30 - 13:30
Drug Company Symposium(Astra Zeneca)
Chairpersons: Galal El-Said, MD; Ahmed Rozza, MD; Omar Awwad, MD; Yasser Sharaf, MD
Chairpersons: M. Mohsen Ibrahim, MD; Soliman Gharieb, MD; Wafaa El-Aroussy, MD
11:00-11:25 What should the hypertension specialist know about genetics?
Hussien Rizk
11:25-11:30 Discussion
11:30-11:55 Vascular phenotyping: What does research tell us?
Christian Delles
11:55-12:00 Discussion
12:00- 12:30 Coffee break
12:30-12:55 HOT trial revisited: role of combination therapy
Hussien Rizk
12:55-13:00 Discussion
13:00-13:25 Hypertension and diabetes Wafaa El-Aroussy
13:25-13:30 Discussion
We
dn
es
da
y
17
th Ap
ril
20
13
14
We
dn
es
da
y
17
th A
pr
il 2
01
3Session (IV) 13:30 – 15:00
Plenary Lecture III 15:00 – 15:30
Egyptian Hypertension Guidelines- Update 2013
Chairpersons: Christian Delles, MD; Ahmed Magdy, MD Hussien Rizk, MD; M. Mohsen Ibrahim, MD
Chairpersons: Mohamed Wafaie, MD; Sherif El-Tobgy, MD, Sameh Emil, MD
13:30-14:00 New Egyptian guidelines M. Mohsen Ibrahim
14:00-14:20 Debate about thresholds: what is relevant?
Mohamed Oraby
14:20-14:40 Problems of implementation Hany Ragy
14:40-15:00 Addressing treatment gaps in the community control of hypertension
Garry Jennings
15:00-15:25 Hypertension: Diagnosis & Management International Guidelines
Christian Delles
15:25-15:30 Discussion
15
Hypertension and Stroke
Chairpersons: Christian Delles, MD; Khaled Shoukry, MD; M. Mohsen Ibrahim, MD; Ramez Guindy, MD Zeinab Ashour, MD
16:00-16:15 Treating blood pressure for pre-vention of stroke: Message from clinical trials
Khaled Baraka
16:15-16:20 Discussion
16:20-16:35 Management of blood pressure during acute phase & after
Hossam Kandil
16:35-16:40 Discussion
16:40-16:55 Neurologist perspectives in hypertension with stroke
Sherif Hamdy
16:55-17:00 Discussion
17:00 Adjourn & Lunch
National Anthem
Welcome Address Wafaa El-Aroussy
Activities of the year 2012 Hussien Rizk
Public awareness in Egyptian Community
Soliman GhariebMuhamed H. Mesalm
ongoing and Future Activities M. Mohsen Ibrahim
Opening Ceremony 15:30-16:00W
ed
ne
sd
ay
1
7th A
pr
il 2
01
3
Session (V) 16:00 - 17:00
18
Th
ur
sd
ay
18
th A
pr
il 2
01
3Session (VI) 9:00 - 9:30
Session (VII) 9:30-10:00
Case Presentation and Imaging Challenge
EHS Research
Chairpersons: Garry Jennings, MD; Ezz El-Din El-Sawy, MD; Khaled Sorour, MD; Magdy Abdel Hamid, MD Nashwa El-Hagrasy, MD
Chairpersons: Ahmed Abdel Latief Ramadan, MD; Azza Eraki, MD; Christian Delles, MD; Hesham Boshra, MD
9:00-9:10 Case 1: Resistant hypertension
Ehab El-HefnyAl-Azhar University
9:10-9:15 Discussion
9:15-9:25 Case 2: Resistant hypertension
Ayman Abol MagdAl-Azhar University
9:25-9:30 Discussion
9:30-9:55 Cardiovascular risk pro-file in Egyptian University Students
Azza Farrag
9:55-10:00 Discussion
19
Th
ur
sd
ay
18
th Ap
ril
20
13
Physiology & Beyond
“Sponsored by Boehringer Ingelheim”
Chairpersons: Abdel Moaty El-Kiey, MD; Aziz Madkour, MD; Hanaa Ferieg, MD; Yasser Baghdady, MD
Chairpersons: M. Mohsen Ibrahim, MD; Ramzy El-Mawardy, MD; Wafaa El-Aroussy, MD
Session (VIII) 10:00-11:00
State-of-the- Art Lecture (I) 11:00 - 11:30
10:00-10:25 Pathophysiology of vascular stiffness
Abdelmoniem Ibrahim
10:25-10:30 Discussion
10:30-10:55 Arterial compliance: How to? When to? Limitations
Essam Baligh
10:55-11:00 Discussion
11:00-11:25 When selecting an ARB… Look deeper
Omar Awwad
11:25-11:30 Discussion
20
Session (IX) 11:30 - 12:30
Session (X) 13:00- 14:00
Hypertension in Clinical Situation
Innovations In Hypertension 2013: A New Approach To Resistant Hypertension
Chairpersons: Ashraf Reda, MD; Fathy Maklady, MD; Fayez Fayek,MD; Iman El-Safty, MD; Khaled El-Rabbat, MD
Chairpersons: Hesham Hegazy, MD; Mohamed Abdel Ghany, MD; Mohamed Sobhy, MD; Wael El-Naggar, MD
11:30-11:55 Hypertension to Heart failure vast knowledge, minimal action
Hussien Rizk
11:55-12:00 Discussion
12:00-12:25 What is new in the management of hypertension in pregnancy
Karim Said
12:25-12:30 Discussion
12:30-13:00 Coffee Break
13:00-13:25 Novel approaches to the manage-ment of resistant hypertension
Garry Jennings
13:25-13:30 Discussion
13:30-13:50 Renal sympathetic denervation: procedure, merits and limitations
Mohamed Abdel Maguid
13:50-14:00 Discussion
Th
ur
sd
ay
18
th A
pr
il 2
01
3
21
14:45-15:10 The use of devices in resistant hypertension
Soliman Gharieb
15:10-15:15 Discussion
15:15-15:40 Blood pressure variability: what do we need to know?
Ahmed El-Hawary
15:40-15:45 Discussion
Drug Company Symposium (Novartis)
Chairpersons: M. Mohsen Ibrahim, MD; Soliman Gharieb, MD; Wafaa ElAroussy, MD
Chairpersons: Abdel Fatah Frere, MD; Hesham Abol Enien, MD; Medhat Ashmawy, MD; Osama Sanad, MD; Wagdy Ayad, MD
Session (XI) 14:00 - 14:45
State-of-the-Art (II) 14:45-15:45
14:00-14:20 Combination Therapy: Which, When, Why?
Adel El Etriby
14:20-14:40 RAAS Blockade – The foundation Therapy In Modern Approach For Hypertension Management
Mahmoud Hassanein
14:40-14:45 Discussion
Th
ur
sd
ay
18
th Ap
ril
20
13
22
Session (XII) 15:45-17:00
Closing Remarks 17:00-17:30
Blood Pressure and Diabetes Mellitus
Chairpersons: Atef El-Bahry, MD; Gamela M. Nasr, MD; Maher Fouad Ramzy, MD; Sherif Hafez, MD
15:45-16:05 Nephroprotection beyond RAAS blockade
Omar El-Khashab
16:05-16:10 Discussion
16:10-16:30 Defining risk in hypertension- beyond clinic blood pressure
Garry Jennings
16:30-16:35 Discussion
16:35-16:55 New antidiabetic agents: Value in hypertensive patients Amr Al-Meligi
16:55-17:00 Discussion
17:00-17:05 Thank-You note Wafaa El-Aroussy
17:05-17:15 Meeting in Minutes Hussien Rizk
17:15-17:30 President of the Society M. Mohsen Ibrahim
17:30 Adjourn & Lunch
Th
ur
sd
ay
18
th A
pr
il 2
01
3
Note.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................
Note.................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................